Although T1DM cannot be prevented yet, important advances have been made in our understanding of its pathogenesis. Of particular relevance is our improved understanding of the role of innate immunity ...

Treatment of type 1 diabetes mellitus (T1DM) for individuals over the age of 30 years is often delayed. A recent large-scale population analysis used a genetic risk score to define T1DM in the first ...

In a recent study published in the Journal of Infection and Public Health, researchers reviewed the causes of diabetes mellitus (DM), focusing on respiratory viruses, including influenza virus and ...

In early January, the US Food and Drug Administration (FDA) granted an orphan drug status to the immunotherapy drug DV-0100, manufactured by the technology company DiaVacs. 1 This cell-based therapy ...

A new study published in the journal Diabetologia in March 2020 reports that children aged below seven years with type 1 diabetes mellitus (T1DM) have a distinct form of the condition from children ...

HealthDay News — Cardiovascular disease (CVD), a long-term complication of type 1 diabetes mellitus (T1DM), and its associated risk factors and modifiers need to be better managed, according to a ...

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease with a strong inflammatory component. The latest studies indicate that innate immunity and inflammatory mediators have a much broader ...